Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Endocare

This article was originally published in The Gray Sheet

Executive Summary

Endocare: Receives investigational device exemption to begin human clinical trials of its CRYOcare 1-Probe cryosurgical system for arresting abnormal uterine bleeding. To effect the treatment, the system's probe is used in conjunction with gel placed in the uterine cavity to freeze endometrial tissue. Endocare claims CRYOcare is more effective than other minimally invasive procedures because the treatment conforms to the shape of the uterus. The firm received 510(k) clearance to market the system for general gynecological use in 1996 and hopes to market the device as an alternative to hysterectomy in some patients...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT008767

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel